Aytu BioPharma, Inc.
Aytu BioPharma, Inc. (AYTU) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AYTU · as of Jun 8, 2026
Key Statistics
Explore Aytu BioPharma, Inc. Data
aytu stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
Competitors & Peers
aytu competitorsAYTU
ADAP
ALUR
ANL
BFRI
EKSOStock Performance
Full HistoryAbout Aytu BioPharma, Inc.
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international m…
what is aytu biopharma, inc. · aytu stock overview · aytu biopharma, inc. company profile · who is aytu biopharma, inc. ceo · aytu NASDAQ · aytu biopharma, inc. headquarters · aytu biopharma, inc. business segments
About Stock Overview & Key Data
Aytu BioPharma, Inc. (AYTU) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Sep 25, 2008. As of the latest trading session, AYTU stock price is $2.29, with a market capitalization of $18.5M. The stock has returned +7.39% over the past 12 months and -12.85% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Aytu BioPharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Aytu BioPharma, Inc. reported revenue of $66.4M and net income of -$13.6M. For detailed data — including Aytu BioPharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aytu BioPharma, Inc. (AYTU) stock price is $2.29. The stock is traded on NASDAQ under the ticker symbol AYTU. The 52-week range is $1.46 – $3.07.